Report Detail

Request for Sample of this report

Other Global Competent Cells Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4652485
    • |
  • 05 December, 2025
    • |
  • Global
    • |
  • 145 Pages
    • |
  • GIR
    • |
  • Other

According to our (Global Info Research) latest study, the global Competent Cells market size was valued at US$ 2451 million in 2024 and is forecast to a readjusted size of USD 4530 million by 2031 with a CAGR of 9.3% during review period.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
This report is a detailed and comprehensive analysis for global Competent Cells market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Competent Cells market size and forecasts, in consumption value ($ Million), 2020-2031
Global Competent Cells market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Competent Cells market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Competent Cells market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Competent Cells
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Competent Cells market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, Takara Bio, Promega Corporation, Beijing TransGen Biotech, GeneScript Corporation, Yeastern Biotech, New England Biolabs, QIAGEN N.V., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Competent Cells market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chemically Competent Cells
Electrocompetent Cells
Market segment by Application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)
Market segment by players, this report covers
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Competent Cells product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Competent Cells, with revenue, gross margin, and global market share of Competent Cells from 2020 to 2025.
Chapter 3, the Competent Cells competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Competent Cells market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Competent Cells.
Chapter 13, to describe Competent Cells research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Competent Cells by Type
    • 1.3.1 Overview: Global Competent Cells Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Competent Cells Consumption Value Market Share by Type in 2024
    • 1.3.3 Chemically Competent Cells
    • 1.3.4 Electrocompetent Cells
  • 1.4 Global Competent Cells Market by Application
    • 1.4.1 Overview: Global Competent Cells Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Subcloning & Routine Cloning
    • 1.4.3 Phage Display Library Construction
    • 1.4.4 Toxic/Unstable DNA Cloning
    • 1.4.5 High-Throughput Cloning
    • 1.4.6 Protein Expression
    • 1.4.7 Mutagenesis
    • 1.4.8 Single-Stranded DNA Production
    • 1.4.9 Bacmid Creation
    • 1.4.10 Cre-Lox Recombination (PIR1/PIR2)
  • 1.5 Global Competent Cells Market Size & Forecast
  • 1.6 Global Competent Cells Market Size and Forecast by Region
    • 1.6.1 Global Competent Cells Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Competent Cells Market Size by Region, (2020-2031)
    • 1.6.3 North America Competent Cells Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Competent Cells Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Competent Cells Market Size and Prospect (2020-2031)
    • 1.6.6 South America Competent Cells Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Competent Cells Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Merck KGaA
    • 2.1.1 Merck KGaA Details
    • 2.1.2 Merck KGaA Major Business
    • 2.1.3 Merck KGaA Competent Cells Product and Solutions
    • 2.1.4 Merck KGaA Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Merck KGaA Recent Developments and Future Plans
  • 2.2 Thermo Fisher Scientific
    • 2.2.1 Thermo Fisher Scientific Details
    • 2.2.2 Thermo Fisher Scientific Major Business
    • 2.2.3 Thermo Fisher Scientific Competent Cells Product and Solutions
    • 2.2.4 Thermo Fisher Scientific Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.3 Agilent Technologies
    • 2.3.1 Agilent Technologies Details
    • 2.3.2 Agilent Technologies Major Business
    • 2.3.3 Agilent Technologies Competent Cells Product and Solutions
    • 2.3.4 Agilent Technologies Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Agilent Technologies Recent Developments and Future Plans
  • 2.4 Takara Bio
    • 2.4.1 Takara Bio Details
    • 2.4.2 Takara Bio Major Business
    • 2.4.3 Takara Bio Competent Cells Product and Solutions
    • 2.4.4 Takara Bio Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Takara Bio Recent Developments and Future Plans
  • 2.5 Promega Corporation
    • 2.5.1 Promega Corporation Details
    • 2.5.2 Promega Corporation Major Business
    • 2.5.3 Promega Corporation Competent Cells Product and Solutions
    • 2.5.4 Promega Corporation Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Promega Corporation Recent Developments and Future Plans
  • 2.6 Beijing TransGen Biotech
    • 2.6.1 Beijing TransGen Biotech Details
    • 2.6.2 Beijing TransGen Biotech Major Business
    • 2.6.3 Beijing TransGen Biotech Competent Cells Product and Solutions
    • 2.6.4 Beijing TransGen Biotech Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Beijing TransGen Biotech Recent Developments and Future Plans
  • 2.7 GeneScript Corporation
    • 2.7.1 GeneScript Corporation Details
    • 2.7.2 GeneScript Corporation Major Business
    • 2.7.3 GeneScript Corporation Competent Cells Product and Solutions
    • 2.7.4 GeneScript Corporation Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 GeneScript Corporation Recent Developments and Future Plans
  • 2.8 Yeastern Biotech
    • 2.8.1 Yeastern Biotech Details
    • 2.8.2 Yeastern Biotech Major Business
    • 2.8.3 Yeastern Biotech Competent Cells Product and Solutions
    • 2.8.4 Yeastern Biotech Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Yeastern Biotech Recent Developments and Future Plans
  • 2.9 New England Biolabs
    • 2.9.1 New England Biolabs Details
    • 2.9.2 New England Biolabs Major Business
    • 2.9.3 New England Biolabs Competent Cells Product and Solutions
    • 2.9.4 New England Biolabs Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 New England Biolabs Recent Developments and Future Plans
  • 2.10 QIAGEN N.V.
    • 2.10.1 QIAGEN N.V. Details
    • 2.10.2 QIAGEN N.V. Major Business
    • 2.10.3 QIAGEN N.V. Competent Cells Product and Solutions
    • 2.10.4 QIAGEN N.V. Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 QIAGEN N.V. Recent Developments and Future Plans
  • 2.11 OriGene Technologies
    • 2.11.1 OriGene Technologies Details
    • 2.11.2 OriGene Technologies Major Business
    • 2.11.3 OriGene Technologies Competent Cells Product and Solutions
    • 2.11.4 OriGene Technologies Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 OriGene Technologies Recent Developments and Future Plans
  • 2.12 Lucigen
    • 2.12.1 Lucigen Details
    • 2.12.2 Lucigen Major Business
    • 2.12.3 Lucigen Competent Cells Product and Solutions
    • 2.12.4 Lucigen Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Lucigen Recent Developments and Future Plans
  • 2.13 Zymo Research
    • 2.13.1 Zymo Research Details
    • 2.13.2 Zymo Research Major Business
    • 2.13.3 Zymo Research Competent Cells Product and Solutions
    • 2.13.4 Zymo Research Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Zymo Research Recent Developments and Future Plans
  • 2.14 Bio-Rad Laboratories
    • 2.14.1 Bio-Rad Laboratories Details
    • 2.14.2 Bio-Rad Laboratories Major Business
    • 2.14.3 Bio-Rad Laboratories Competent Cells Product and Solutions
    • 2.14.4 Bio-Rad Laboratories Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.15 Bioline
    • 2.15.1 Bioline Details
    • 2.15.2 Bioline Major Business
    • 2.15.3 Bioline Competent Cells Product and Solutions
    • 2.15.4 Bioline Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.15.5 Bioline Recent Developments and Future Plans
  • 2.16 Delphi Genetics
    • 2.16.1 Delphi Genetics Details
    • 2.16.2 Delphi Genetics Major Business
    • 2.16.3 Delphi Genetics Competent Cells Product and Solutions
    • 2.16.4 Delphi Genetics Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.16.5 Delphi Genetics Recent Developments and Future Plans
  • 2.17 IBA GmBH
    • 2.17.1 IBA GmBH Details
    • 2.17.2 IBA GmBH Major Business
    • 2.17.3 IBA GmBH Competent Cells Product and Solutions
    • 2.17.4 IBA GmBH Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.17.5 IBA GmBH Recent Developments and Future Plans
  • 2.18 Cell Applications
    • 2.18.1 Cell Applications Details
    • 2.18.2 Cell Applications Major Business
    • 2.18.3 Cell Applications Competent Cells Product and Solutions
    • 2.18.4 Cell Applications Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.18.5 Cell Applications Recent Developments and Future Plans
  • 2.19 BioDynamics Laboratory
    • 2.19.1 BioDynamics Laboratory Details
    • 2.19.2 BioDynamics Laboratory Major Business
    • 2.19.3 BioDynamics Laboratory Competent Cells Product and Solutions
    • 2.19.4 BioDynamics Laboratory Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.19.5 BioDynamics Laboratory Recent Developments and Future Plans
  • 2.20 Scarab Genomics
    • 2.20.1 Scarab Genomics Details
    • 2.20.2 Scarab Genomics Major Business
    • 2.20.3 Scarab Genomics Competent Cells Product and Solutions
    • 2.20.4 Scarab Genomics Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.20.5 Scarab Genomics Recent Developments and Future Plans
  • 2.21 GCC Biotech
    • 2.21.1 GCC Biotech Details
    • 2.21.2 GCC Biotech Major Business
    • 2.21.3 GCC Biotech Competent Cells Product and Solutions
    • 2.21.4 GCC Biotech Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.21.5 GCC Biotech Recent Developments and Future Plans
  • 2.22 SMOBIO Technology
    • 2.22.1 SMOBIO Technology Details
    • 2.22.2 SMOBIO Technology Major Business
    • 2.22.3 SMOBIO Technology Competent Cells Product and Solutions
    • 2.22.4 SMOBIO Technology Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.22.5 SMOBIO Technology Recent Developments and Future Plans
  • 2.23 Edge BioSystems
    • 2.23.1 Edge BioSystems Details
    • 2.23.2 Edge BioSystems Major Business
    • 2.23.3 Edge BioSystems Competent Cells Product and Solutions
    • 2.23.4 Edge BioSystems Competent Cells Revenue, Gross Margin and Market Share (2020-2025)
    • 2.23.5 Edge BioSystems Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Competent Cells Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Competent Cells by Company Revenue
    • 3.2.2 Top 3 Competent Cells Players Market Share in 2024
    • 3.2.3 Top 6 Competent Cells Players Market Share in 2024
  • 3.3 Competent Cells Market: Overall Company Footprint Analysis
    • 3.3.1 Competent Cells Market: Region Footprint
    • 3.3.2 Competent Cells Market: Company Product Type Footprint
    • 3.3.3 Competent Cells Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Competent Cells Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Competent Cells Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Competent Cells Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Competent Cells Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Competent Cells Consumption Value by Type (2020-2031)
  • 6.2 North America Competent Cells Market Size by Application (2020-2031)
  • 6.3 North America Competent Cells Market Size by Country
    • 6.3.1 North America Competent Cells Consumption Value by Country (2020-2031)
    • 6.3.2 United States Competent Cells Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Competent Cells Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Competent Cells Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Competent Cells Consumption Value by Type (2020-2031)
  • 7.2 Europe Competent Cells Consumption Value by Application (2020-2031)
  • 7.3 Europe Competent Cells Market Size by Country
    • 7.3.1 Europe Competent Cells Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Competent Cells Market Size and Forecast (2020-2031)
    • 7.3.3 France Competent Cells Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Competent Cells Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Competent Cells Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Competent Cells Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Competent Cells Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Competent Cells Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Competent Cells Market Size by Region
    • 8.3.1 Asia-Pacific Competent Cells Consumption Value by Region (2020-2031)
    • 8.3.2 China Competent Cells Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Competent Cells Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Competent Cells Market Size and Forecast (2020-2031)
    • 8.3.5 India Competent Cells Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Competent Cells Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Competent Cells Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Competent Cells Consumption Value by Type (2020-2031)
  • 9.2 South America Competent Cells Consumption Value by Application (2020-2031)
  • 9.3 South America Competent Cells Market Size by Country
    • 9.3.1 South America Competent Cells Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Competent Cells Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Competent Cells Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Competent Cells Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Competent Cells Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Competent Cells Market Size by Country
    • 10.3.1 Middle East & Africa Competent Cells Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Competent Cells Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Competent Cells Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Competent Cells Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Competent Cells Market Drivers
  • 11.2 Competent Cells Market Restraints
  • 11.3 Competent Cells Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Competent Cells Industry Chain
  • 12.2 Competent Cells Upstream Analysis
  • 12.3 Competent Cells Midstream Analysis
  • 12.4 Competent Cells Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Competent Cells. Industry analysis & Market Report on Competent Cells is a syndicated market report, published as Global Competent Cells Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Competent Cells market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo